These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35549453)

  • 1. Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer.
    Stephenson AJ; Vourganti S
    J Urol; 2022 Aug; 208(2):246-247. PubMed ID: 35549453
    [No Abstract]   [Full Text] [Related]  

  • 2. Con: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer.
    Siddiqui MM
    J Urol; 2022 Aug; 208(2):248-249. PubMed ID: 35549452
    [No Abstract]   [Full Text] [Related]  

  • 3. When to Order an MRI in the Initial Evaluation and Management of Prostate Cancer.
    Walton-Diaz A; Rais-Bahrami S
    Oncology (Williston Park); 2018 Oct; 32(10):501-4. PubMed ID: 30334240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging cognitive fusion biopsy - is near enough good enough?
    Sathianathen NJ; Christidis D; Konety BR; Lawrentschuk NL
    BJU Int; 2018 Mar; 121(3):324-326. PubMed ID: 29237233
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
    Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions.
    Gosein M; Pang E; Chang S; Black P; Goldenberg L; Harris A; Yasenjiang J; Yousefi M
    Can Assoc Radiol J; 2018 Aug; 69(3):303-310. PubMed ID: 29895436
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate MR Imaging: An Update.
    Shaish H; Taneja SS; Rosenkrantz AB
    Radiol Clin North Am; 2017 Mar; 55(2):303-320. PubMed ID: 28126217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-guided transperineal prostate biopsy.
    Chen J; Lin Z; Chen J; Lin Q; Chen J; Yan Y
    J Cancer Res Ther; 2019; 15(2):394-397. PubMed ID: 30964117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.
    Leveridge M; Siemens DR
    Eur Urol; 2022 Oct; 82(4):440. PubMed ID: 35907661
    [No Abstract]   [Full Text] [Related]  

  • 11. [Not Available].
    Klingebiel M; Ullrich T; Rabenalt R; Albers P; Antoch G; Schimmöller L
    Rofo; 2018 Nov; 190(11):1067-1069. PubMed ID: 29874701
    [No Abstract]   [Full Text] [Related]  

  • 12. Words of wisdom. Re: A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Kim EH; Johnson MH; Andriole GL
    Eur Urol; 2014 Sep; 66(3):595. PubMed ID: 25306180
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproducibility of Multiparametric Magnetic Resonance Imaging and Fusion Guided Prostate Biopsy: Multi-Institutional External Validation by a Propensity Score Matched Cohort.
    Rastinehad AR; Abboud SF; George AK; Frye TP; Ho R; Chelluri R; Fascelli M; Shih J; Villani R; Ben-Levi E; Yaskiv O; Turkbey B; Choyke PL; Merino MJ; Wood BJ; Pinto PA
    J Urol; 2016 Jun; 195(6):1737-43. PubMed ID: 26812301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
    Vourganti S; Rastinehad A; Yerram N; Nix J; Volkin D; Hoang A; Turkbey B; Gupta GN; Kruecker J; Linehan WM; Choyke PL; Wood BJ; Pinto PA
    J Urol; 2012 Dec; 188(6):2152-2157. PubMed ID: 23083875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.
    Logan JK; Rais-Bahrami S; Turkbey B; Gomella A; Amalou H; Choyke PL; Wood BJ; Pinto PA
    BJU Int; 2014 Nov; 114(5):641-52. PubMed ID: 24298917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
    Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
    BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling.
    Chelluri R; Kilchevsky A; George AK; Sidana A; Frye TP; Su D; Fascelli M; Ho R; Abboud SF; Turkbey B; Merino MJ; Choyke PL; Wood BJ; Pinto PA
    J Urol; 2016 Jul; 196(1):62-7. PubMed ID: 26880408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
    Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
    J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precision of prostate magnetic resonance imaging for the detection of clinically significant prostate cancer].
    Krafft U; Borkowetz A
    Urologe A; 2020 Jan; 59(1):72-77. PubMed ID: 31832747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.